Kingfa Science & Technology (India)
- P/E
- 40.93
Key Fundamentals
MicrocapIndustrial ProductsCapital GoodsPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 23.20%
- Debt to Equity
- 0.01
- EPS (TTM)
- ₹166.53
- Book Value
- ₹1,032.59
- Market Cap
- —
- P/E (TTM)
- 40.93
- P/B
- 6.60
- ROE
- 17.40%
- Dividend Yield
- 0.30%
- EBITDA
- ₹282 Cr
- 52W High
- ₹6,997.00
- 52W Low
- ₹3,649.90
- Day Range
- ₹6,685.50 – ₹6,852.00
- Volume
- 3,396
Peer Comparison
Industrials › Industrial Products › Plastic Products - Industrial
| ₹3,353.50 | 41.26 | ₹42,083 Cr | 6.66 | 0.36% | 15.80% | 20.70% | ₹11,326 Cr | ₹1,033 Cr | |
| ₹1,423.70 | 66.43 | ₹37,224 Cr | 9.43 | 0.29% | 13.80% | 19.20% | ₹6,785 Cr | ₹576 Cr | |
| ₹7,544.50 | 45.19 | ₹17,078 Cr | 6.03 | 0.16% | 13.50% | 18.10% | ₹2,258 Cr | ₹388 Cr | |
| Kingfa Science & Technology (this company) | ₹6,816.50 | 40.93 | ₹9,153 Cr | 6.60 | 0.30% | 17.40% | 23.20% | ₹2,222 Cr | ₹225 Cr |
| ₹143.95 | 14.51 | ₹8,730 Cr | 1.18 | 1.99% | 8.57% | 11.80% | ₹3,954 Cr | ₹616 Cr | |
| ₹171.42 | 16.94 | ₹8,407 Cr | 2.07 | 0.90% | 13.10% | 16.50% | ₹6,445 Cr | ₹498 Cr | |
| ₹297.75 | 32.26 | ₹3,136 Cr | 2.00 | 0.36% | 4.60% | 6.03% | ₹2,627 Cr | ₹103 Cr | |
| Median 7 companies | ₹1,423.70 | 40.93 | ₹9,153 Cr | 6.03 | 0.36% | 13.50% | 18.10% | ₹3,954 Cr | ₹498 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 44
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 44
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 64
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 86
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 72
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 35
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
5- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 103% CAGR over last 5 years
- Company's median sales growth is 16.9% of last 10 years
Weaknesses
1- Promoter holding has decreased over last 3 years: -7.97%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 2 | 5 | 12 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Neutral
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 59.42
- Neutral
- MACD (12,26,9)
- 124.85
- Bearish
- SMA (50)
- 6,342.23
- Bullish
- SMA (200)
- 5,184.83
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +20.32% |
|---|---|
| 5Y | +26.06% |
| 3Y | +12.44% |
| 1Y | +14.38% |
| TTM | +24.13% |
Net profit
| 10Y | +32.61% |
|---|---|
| 5Y | +105.89% |
| 3Y | +31.69% |
| 1Y | +20.92% |
| TTM | +46.10% |
Operating cash flow
| 10Y | +13.26% |
|---|---|
| 5Y | Turned positive |
| 3Y | +34.71% |
| 1Y | +10.00% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +4.48 pp |
|---|---|
| 5Y | +9.89 pp |
| 3Y | +3.96 pp |
| 1Y | +0.19 pp |
| TTM | +1.61 pp |
Revenue by year
| Mar 2017 | ₹427 Cr |
|---|---|
| Mar 2018 | ₹602 Cr |
| Mar 2019 | ₹702 Cr |
| Mar 2020 | ₹742 Cr |
| Mar 2021 | ₹627 Cr |
| Mar 2022 | ₹1,048 Cr |
| Mar 2023 | ₹1,404 Cr |
| Mar 2024 | ₹1,488 Cr |
| Mar 2025 | ₹1,745 Cr |
| Mar 2026 | ₹1,996 Cr |
Net profit by year
| Mar 2017 | ₹12.00 Cr |
|---|---|
| Mar 2018 | ₹25.00 Cr |
| Mar 2019 | ₹19.00 Cr |
| Mar 2020 | ₹25.00 Cr |
| Mar 2021 | ₹5.00 Cr |
| Mar 2022 | ₹31.00 Cr |
| Mar 2023 | ₹81.00 Cr |
| Mar 2024 | ₹123 Cr |
| Mar 2025 | ₹153 Cr |
| Mar 2026 | ₹185 Cr |
AI Analysis — Bull vs Bear
Kingfa Science & Technology (India) Ltd is a Rs 6,912 Cr market cap industrials company trading at a PE of 37.6x with strong historical profit growth of 103% CAGR over 5 years and 12% sales CAGR over 3 years. The company is virtually debt-free but trades at a premium valuation of 4.98x price-to-book with a negligible 0.2% dividend yield despite consistent profitability.
- Exceptional 5-year compounded profit growth of 103% CAGR demonstrates strong earnings scalability
- Company is almost debt-free, providing financial flexibility and lower interest cost burden
- Consistent ROE averaging 19% over 5 years and 20% over 3 years indicates efficient capital deployment
- 10-year median sales growth of 16.9% reflects sustained demand for its specialty polymer products
- TTM profit growth of 21% shows continued earnings momentum even on a larger base
- 5-year stock CAGR of 34% reflects sustained re-rating driven by improving fundamentals
- Active debt reduction strategy has strengthened the balance sheet and reduced financial risk
- TTM sales growth of 14% indicates the top-line continues to expand in the current period
- Promoter holding has declined by 7.97% over 3 years, signaling potential reduced insider confidence
- Dividend yield of just 0.2% despite repeated profits suggests poor capital return to minority shareholders
- Price-to-book of 4.98x is steep relative to historical book value, implying high expectations are priced in
- 3-year sales CAGR of 12% is notably lower than the 5-year CAGR of 26%, indicating a deceleration in top-line growth
- Last year ROE of 17% has declined from the 3-year average of 20%, showing some pressure on return ratios
- 1-year stock CAGR of 50% significantly outpaces TTM profit growth of 21%, suggesting valuation has run ahead of fundamentals
- As a subsidiary of a Chinese parent, the company faces geopolitical and regulatory risks specific to Indo-China business relations
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Limited news flow for Kingfa Science & Technology with only a routine regulatory disclosure confirming no promoter share pledging in FY26. No identifiable headwinds or positive catalysts from recent coverage. The lack of news makes it difficult to assess whether the trend is improving or deteriorating; investors should watch for upcoming quarterly results and operational updates for directional cues.
- No promoter share encumbrance Jun 15
Kingfa Science & Technology (India) Ltd disclosed to BSE and NSE that promoters created no encumbrance on shares during FY26, indicating clean promoter holdings.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 339 | 351 | 394 | 404 | 416 | 418 | 440 | 470 | 462 | 466 | 489 | 578 | 689 |
| Expenses | 289 | 306 | 356 | 354 | 359 | 362 | 389 | 409 | 404 | 405 | 428 | 497 | 578 |
| Operating Profit | 50 | 45 | 38 | 51 | 57 | 56 | 51 | 60 | 58 | 61 | 62 | 81 | 111 |
| OPM % | 15% | 13% | 10% | 13% | 14% | 13% | 12% | 13% | 13% | 13% | 13% | 14% | 16% |
| Other Income | 2 | 0 | 1 | 2 | 2 | 1 | 5 | 2 | 4 | 3 | 7 | 7 | 5 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 8 |
| PBT | 47 | 40 | 32 | 45 | 52 | 50 | 49 | 54 | 54 | 55 | 61 | 80 | 108 |
| Tax % | 25% | 25% | 25% | 26% | 25% | 26% | 30% | 23% | 26% | 26% | 26% | 26% | 25% |
| Net Profit | 35 | 30 | 24 | 34 | 39 | 37 | 35 | 42 | 40 | 41 | 45 | 59 | 80 |
| EPS (₹) | 28.93 | 24.44 | 20.09 | 27.7 | 32.26 | 30.77 | 28.6 | 34.6 | 32.86 | 30.36 | 33.33 | 43.65 | 59.19 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 219 | 314 | 427 | 602 | 702 | 742 | 627 | 1,048 | 1,404 | 1,488 | 1,745 | 1,996 | 2,222 |
| Expenses | 212 | 288 | 408 | 560 | 666 | 698 | 607 | 966 | 1,276 | 1,303 | 1,520 | 1,734 | 1,908 |
| Operating Profit | 6 | 27 | 19 | 41 | 35 | 43 | 20 | 82 | 128 | 185 | 225 | 261 | 314 |
| OPM % | 3% | 8% | 4.5% | 7% | 5% | 6% | 3.2% | 8% | 9% | 12% | 13% | 13% | 14% |
| Other Income | 0 | 1 | 4 | 6 | 4 | 3 | 6 | −22 | 2 | 3 | 9 | 21 | 22 |
| Interest | 8 | 7 | 2 | 2 | 2 | 4 | 3 | 5 | 7 | 6 | 7 | 4 | 3 |
| Depreciation | 3 | 3 | 3 | 6 | 8 | 9 | 11 | 13 | 14 | 18 | 22 | 28 | 30 |
| PBT | −5 | 17 | 18 | 39 | 29 | 33 | 12 | 41 | 110 | 164 | 206 | 250 | 303 |
| Tax % | −35% | 38% | 30% | 36% | 35% | 26% | 55% | 26% | 26% | 25% | 26% | 26% | — |
| Net Profit | −3 | 11 | 12 | 25 | 19 | 25 | 5 | 31 | 81 | 123 | 153 | 185 | 226 |
| EPS (₹) | −2.49 | 8.93 | 10.24 | 20.35 | 15.74 | 20.33 | 4.39 | 25.29 | 67.22 | 101 | 126 | 137 | 167 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% | 15% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 10 | 10 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 14 |
| Reserves | 2 | 109 | 234 | 293 | 312 | 336 | 342 | 372 | 454 | 576 | 716 | 1,386 |
| Borrowings | 75 | 16 | 42 | 21 | 17 | 46 | 71 | 46 | 42 | 33 | 43 | 15 |
| Other Liabilities | 41 | 95 | 119 | 159 | 210 | 202 | 246 | 449 | 502 | 373 | 384 | 339 |
| Total Liabilities | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,156 | 1,754 |
| Fixed Assets | 25 | 29 | 76 | 88 | 85 | 107 | 129 | 126 | 123 | 252 | 244 | 300 |
| CWIP | 1 | 41 | 10 | 2 | 79 | 115 | 123 | 127 | 131 | 2 | 41 | 61 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 99 | 160 | 319 | 395 | 388 | 375 | 419 | 627 | 756 | 740 | 871 | 1,393 |
| Total Assets | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,156 | 1,754 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | −1 | 19 | −119 | −116 | 96 | 30 | −2 | 38 | 27 | 16 | 60 | 66 |
| Investing | −4 | −47 | −18 | −6 | −77 | −63 | −14 | −19 | −12 | 2 | −30 | −392 |
| Financing | 5 | 34 | 137 | 14 | −7 | 22 | 17 | −14 | −21 | −8 | −7 | 438 |
| Net Cash Flow | 0 | 6 | −1 | −108 | 12 | −11 | 1 | 5 | −6 | 10 | 23 | 112 |
| Free Cash Flow | −5 | −28 | −138 | −127 | 14 | −35 | −17 | 19 | 3 | −5 | 30 | −45 |
| CFO/OP | −13 | 72 | −602 | −256 | 300 | 111 | 5 | 63 | 35 | 29 | 56 | 48 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93 | 99 | 111 | 110 | 109 | 97 | 123 | 99 | 93 | 99 | 93 | 98 |
| Inventory Days | 64 | 85 | 69 | 85 | 63 | 67 | 100 | 110 | 94 | 76 | 82 | 78 |
| Days Payable | 72 | 127 | 108 | 108 | 119 | 115 | 152 | 181 | 155 | 110 | 94 | 75 |
| Cash Conversion Cycle | 85 | 57 | 72 | 86 | 53 | 49 | 71 | 28 | 32 | 66 | 80 | 100 |
| Working Capital Days | −14 | 66 | 59 | 96 | 59 | 55 | 57 | 39 | 45 | 78 | 85 | 113 |
| ROCE % | 4% | 22% | 9% | 13% | 9% | 10% | 4% | 16% | 25% | 30% | 31% | 23% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Kingfa Science & Technology insights
61 extracted metrics across FY10–FY27.
Documents
- 29 May 2026
- 30 Jul 2025
- General announcements 6 Oct 2026
Frequently Asked Questions about Kingfa Science & Technology (India)
What does Kingfa Science & Technology (India) Ltd do?
Where is Kingfa Science & Technology (India) Ltd (KINGFA) listed?
Which sector does Kingfa Science & Technology (India) Ltd belong to?
What is the PE ratio of Kingfa Science & Technology (India) Ltd?
What is the 52-week high and low of Kingfa Science & Technology (India) Ltd?
Does Kingfa Science & Technology (India) Ltd pay dividends?
What is the Return on Equity (ROE) of Kingfa Science & Technology (India) Ltd?
Company Information
Kingfa Science & Technology (India) Limited, a subsidiary company of M/s Kingfa Science & Technology Co. Ltd China, is engaged in the business of manufacturing and supply of high-quality modified plastic compounds for automotive and consumer products and personal protective equipments like masks and gloves.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/KINGFA.md for Kingfa Science & Technology (India) Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.